Published in Antiviral Res on September 01, 1995
Genotypic testing for human immunodeficiency virus type 1 drug resistance. Clin Microbiol Rev (2002) 3.27
Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population. J Infect Dis (2001) 1.97
Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads. J Virol (2004) 1.85
Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine. Antimicrob Agents Chemother (1998) 1.21
The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors. AIDS Rev (2000) 1.15
A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies. HIV Seq Compend (2001) 0.98
Use of tissue culture cell lines to evaluate HIV antiviral resistance. AIDS Res Hum Retroviruses (2008) 0.93
Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection. Antimicrob Agents Chemother (1996) 0.93
Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance. Antimicrob Agents Chemother (2004) 0.87
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science (1986) 4.40
Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science (1994) 3.44
Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother (1997) 2.84
Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. Antimicrob Agents Chemother (1986) 2.70
In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug. Antimicrob Agents Chemother (1985) 2.44
Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. Virology (1995) 2.29
In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease. Proc Natl Acad Sci U S A (1993) 2.16
Celebrities and suicide: a taxonomy and analysis, 1948-1983. Am Sociol Rev (1987) 1.79
Inhibition of poliovirus uncoating by disoxaril (WIN 51711). Virology (1987) 1.73
Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors. AIDS Res Hum Retroviruses (1995) 1.59
[[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating. J Med Chem (1985) 1.49
Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266. AIDS (1996) 1.34
Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case. Rev Infect Dis (1991) 1.29
Physical and biological consequences of incorporation of antiviral agents into virus DNA. Antiviral Res (1984) 1.26
Reducing time limits: a means to increase behavior of retardates. J Appl Behav Anal (1976) 1.24
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob Agents Chemother (1989) 1.22
Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine. Antimicrob Agents Chemother (1998) 1.21
Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas. J Med Chem (1996) 1.20
The effect of religious commitment on suicide: a cross-national analysis. J Health Soc Behav (1983) 1.19
Wound infection and septic shock due to Vibrio vulnificus. Am J Trop Med Hyg (1981) 1.13
Plasmid DNA fingerprinting of Acinetobacter calcoaceticus subspecies anitratus from intubated and mechanically ventilated patients. Infect Control Hosp Epidemiol (1990) 1.12
Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues. J Med Chem (1998) 1.09
The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues. Antivir Chem Chemother (1998) 1.08
Inhibitors of viral uncoating. Pharmacol Ther (1989) 1.07
Pseudoexfoliation and sensorineural hearing loss. Eye (Lond) (2002) 1.07
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450. Chem Biol (1996) 1.06
Protein interactions of Src homology 2 (SH2) domain-containing inositol phosphatase (SHIP): association with Shc displaces SHIP from FcgammaRIIb in B cells. J Immunol (1999) 1.05
Scurvy: MRI appearances. Rheumatology (Oxford) (2008) 1.04
Delayed bactericidal activity of beta-lactam antibiotics against Listeria monocytogenes: antagonism of chloramphenicol and rifampin. Antimicrob Agents Chemother (1983) 1.04
Infant mortality and early postpartum discharge. Obstet Gynecol (2000) 1.04
In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes. Antimicrob Agents Chemother (1982) 1.01
Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis. Clin Cancer Res (1997) 1.00
In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor. Antimicrob Agents Chemother (1993) 1.00
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication. Bioorg Med Chem Lett (2000) 0.99
Enzymatic modifications of human fibroblast and leukocyte interferons. J Virol (1980) 0.96
Protein adsorption and macrophage activation on polydimethylsiloxane and silicone rubber. J Biomater Sci Polym Ed (1995) 0.95
Plasmin binding to the plasminogen receptor enhances catalytic efficiency and activates the receptor for subsequent ligand binding. Arch Biochem Biophys (1991) 0.95
Effectiveness of mattress overlays in reducing interface pressures during recumbency. J Rehabil Res Dev (1985) 0.91
Divorce and suicide: a time series analysis, 1933-1970. J Fam Issues (1981) 0.91
Adhesion and cytokine production by monocytes on poly(2-methacryloyloxyethyl phosphorylcholine-co-alkyl methacrylate)-coated polymers. J Biomed Mater Res (1995) 0.91
Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus. J Med Chem (1989) 0.90
the influence of the host cell on the inhibition of virus protein synthesis in cells double infected with vesicular stomatitis virus and mengovirus. J Gen Virol (1980) 0.90
Use of urine for HIV-1 antibody screening. Lancet (1990) 0.90
Estimating farmworker population size in New York State using a minimum labor demand method. J Agric Saf Health (2005) 0.88
Human monocyte/macrophage adhesion and cytokine production on surface-modified poly(tetrafluoroethylene/hexafluoropropylene) polymers with and without protein preadsorption. J Biomed Mater Res (1995) 0.88
Suicide in Detroit 1975: changes and continuities. Suicide Life Threat Behav (1982) 0.87
HIV protease inhibitors. AIDS (1995) 0.87
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors. J Med Chem (2000) 0.87
Aspartic proteinase genes in the Brassicaceae Arabidopsis thaliana and Brassica napus. Plant Mol Biol (1997) 0.85
The effect of the decline in institutionalized religion on suicide, 1954-1978. J Sci Study Relig (1983) 0.85
Two-dimensional spreads of synaptonemal complexes from solanaceous plants. I. The technique. Stain Technol (1982) 0.85
Inhibitors of picornavirus uncoating as antiviral agents. Pharmacol Ther (1985) 0.84
The effect of television on national suicide rates. J Soc Psychol (1984) 0.84
Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on synthesis of herpes simplex virus type 1-specific polypeptides. Antimicrob Agents Chemother (1984) 0.83
Listeria bacteremia and peritonitis associated with a peritoneovenous shunt: successful treatment with sulfamethoxazole and trimethoprim. J Infect Dis (1984) 0.83
A Comparison of Soybean Agglutinin in Cultivars Resistant and Susceptible to Phytophthora megasperma var. sojae (Race 1). Plant Physiol (1982) 0.82
Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating. J Med Chem (1987) 0.81
Molecular characterization of HIV-2 (ROD) protease following PCR cloning from virus infected H9 cells. Adv Exp Med Biol (1992) 0.81
The effects of interstate migration on suicide. Int J Soc Psychiatry (1980) 0.81
The synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitors. Bioorg Med Chem Lett (1998) 0.80
The sociological study of suicide: methodological issues. Suicide Life Threat Behav (1987) 0.80
Inhibition of the bovine viral diarrhoea virus NS3 serine protease by a boron-modified peptidyl mimetic of its natural substrate. Antivir Chem Chemother (2001) 0.80
Effects of CD45 on NF-kappa B. Implications for replication of HIV-1. J Immunol (1994) 0.79
Enantiomeric effects of homologues of disoxaril on the inhibitory activity against human rhinovirus-14. J Med Chem (1988) 0.78
Effects of nucleoside analogues on the expression of herpes simplex type 1-induced proteins. Antiviral Res (1982) 0.78
The effect of unemployment duration on national suicide rates: a time series analysis, 1948-1982. Sociol Focus (1984) 0.78
The effect of the Jonestown suicides on American suicide rates. J Soc Psychol (1983) 0.78
In vitro susceptibility of clinical isolates of HIV-1 to XM323, a non-peptidyl HIV protease inhibitor. AIDS (1994) 0.77
Ionic modulation of the effects of heparin on plasminogen activation by tissue plasminogen activator: the effects of ionic strength, divalent cations, and chloride. Arch Biochem Biophys (1992) 0.77
Safety, pharmacokinetics, and efficacy of (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine with efavirenz and stavudine in antiretroviral-naïve human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (2005) 0.77
Aphthous ulceration of the gastrointestinal tract in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med (1990) 0.77
Successful therapy with rifampin--flavobacterium meningosepticum meningitis developing while on erythromycin therapy. Del Med J (1982) 0.76
Ventriculoperitoneal shunt infection due to Listeria monocytogenes. Clin Infect Dis (1995) 0.75
The synaptonemal complex and the achiasmatic condition. J Cell Sci (1973) 0.75
Political regime and suicide: some relevant variables to be considered. J Epidemiol Community Health (2002) 0.75
DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants. Antimicrob Agents Chemother (2001) 0.75
Antibiotic choice in the neutropenic patient. Del Med J (1984) 0.75
The Medical Center of Delaware infectious disease clinic. Del Med J (1989) 0.75
Public relations: low key defuses confrontation. Hospitals (1972) 0.75
Cousteau diver impersonated by Munchausen patient. JAMA (1977) 0.75
Severe cellulitis due to Aeromonas hydrophilia following immersion injury. Del Med J (1984) 0.75
Legionnaires' disease. Del Med J (1979) 0.75
HIV update. Del Med J (1989) 0.75
Fibrinoid necrosis in granuloma induced by imcomplete Freund adjuvant. Arch Pathol (1974) 0.75
Protein adsorption and endothelial cell attachment and proliferation on PAPI-based additive modified poly(ether urethane ureas). J Biomed Mater Res (1993) 0.75
Acquired immune deficiency syndrome in Delaware: experience with opportunistic infections and malignancies in 33 patients. Del Med J (1986) 0.75
Informed consent for transfusion. Del Med J (1993) 0.75
Basic biochemical and pharmacological aspects of antiviral agents. Antiviral Res (1985) 0.75
The relationship between the antiviral activity of 5'-amino-5'-deoxythymidine and its incorporation into herpes simplex virus type 1 DNA. Antiviral Res (1984) 0.75
Age, birthdays, and suicide. J Soc Psychol (1994) 0.75
Cefmetazole treatment of intra-abdominal infection. J Antimicrob Chemother (1989) 0.75
Height and risk of suicide. J Soc Psychol (1996) 0.75
Infections due to Cryptococcus neoformans. Del Med J (1985) 0.75
Ciprofloxacin versus ceftazidime in serious infections. Am J Med (1989) 0.75